Based on crystallographic overlays of the known inhibitors TMC125 and R221239 complexed in RT, we designed a novel series of 4-phenoxy-6-(phenylamino)pyridin-2(1H)-one derivatives as HIV NNRTIs by molecular hybridization approach. The biological testing results indicated that 2-pyridone scaffold of these inhibitors was indispensable for their anti-HIV-1 activity, and substitution of halogen at the 3-position of the 2-pyridone ring would decrease the anti-HIV activity. Four most potent compounds had anti-HIV-1 IIIB activities at low micromolar concentrations (EC50=0.15-0.84μM), comparable to that of nevirapine and delavidine. Some compounds were selected to test their anti-HIV-1 RT inhibitory action and to perform molecular modeling studies ...
By means of structure-based molecular hybridization strategy, a series of novel diarylpyri(mi)dine d...
By means of structure-based molecular hybridization strategy, a series of novel diarylpyri(mi)dine d...
Earlier we reported the identification of diarylpyrimidine-quinolone hybrids as a new class of HIV-1...
Based on crystallographic overlays of the known inhibitors TMC125 and R221239 complexed in RT, we de...
A novel 2-pyridinone scaffold was rationally designed and synthesized based on the active anti-HIV a...
Through a structure-based molecular hybridization and bioisosterism approach, a series of novel 2-(p...
Guided by crystal structures of HIV-1 RT/DAPY complex and molecular modeling studies, a series of no...
The development of novel NNRTIs with activity against variants of HIV-1RT is crucial for overcoming ...
A novel series of uracil-bearing DAPYs derivatives were designed and synthesized via structure-based...
A series of novel piperidinylamino-diarylpyrimidine (pDAPY) derivatives with dual structural conform...
As a continuation of our efforts to discover and develop back-up analogs of DAPYs, novel substituted...
In our continued efforts to discover more active and less toxic HIV-1 non-nucleoside reverse transcr...
A novel series of piperidin-4-yl-aminopyrimidine derivatives were designed fusing the pharmacophore ...
Crystallographic overlap studies and pharmacophoric analysis indicated that diarylpyrimidine (DAPY)-...
Crystallographic overlap studies and pharmacophoric analysis indicated that diarylpyrimidine (DAPY)-...
By means of structure-based molecular hybridization strategy, a series of novel diarylpyri(mi)dine d...
By means of structure-based molecular hybridization strategy, a series of novel diarylpyri(mi)dine d...
Earlier we reported the identification of diarylpyrimidine-quinolone hybrids as a new class of HIV-1...
Based on crystallographic overlays of the known inhibitors TMC125 and R221239 complexed in RT, we de...
A novel 2-pyridinone scaffold was rationally designed and synthesized based on the active anti-HIV a...
Through a structure-based molecular hybridization and bioisosterism approach, a series of novel 2-(p...
Guided by crystal structures of HIV-1 RT/DAPY complex and molecular modeling studies, a series of no...
The development of novel NNRTIs with activity against variants of HIV-1RT is crucial for overcoming ...
A novel series of uracil-bearing DAPYs derivatives were designed and synthesized via structure-based...
A series of novel piperidinylamino-diarylpyrimidine (pDAPY) derivatives with dual structural conform...
As a continuation of our efforts to discover and develop back-up analogs of DAPYs, novel substituted...
In our continued efforts to discover more active and less toxic HIV-1 non-nucleoside reverse transcr...
A novel series of piperidin-4-yl-aminopyrimidine derivatives were designed fusing the pharmacophore ...
Crystallographic overlap studies and pharmacophoric analysis indicated that diarylpyrimidine (DAPY)-...
Crystallographic overlap studies and pharmacophoric analysis indicated that diarylpyrimidine (DAPY)-...
By means of structure-based molecular hybridization strategy, a series of novel diarylpyri(mi)dine d...
By means of structure-based molecular hybridization strategy, a series of novel diarylpyri(mi)dine d...
Earlier we reported the identification of diarylpyrimidine-quinolone hybrids as a new class of HIV-1...